Literature DB >> 18655144

Three-dimensional consensus structure of sst2-selective somatostatin (SRIF) antagonists by NMR.

Christy Rani R Grace1, Judit Erchegyi, Jean Claude Reubi, Jean E Rivier, Roland Riek.   

Abstract

The three-dimensional NMR structures of seven octapeptide analogs of somatostatin (SRIF), based on octreotide, with the basic sequence H-Cpa/Phe2-c[DCys3-Xxx7-DTrp/DAph(Cbm)8-Lys9-Thr10-Cys14]-Yyy-NH2 (the numbering refers to the position in native SRIF), with Xxx7 being Aph(Cbm)/Tyr/Agl(NMe,benzoyl) and Yyy being Nal/DTyr/Thr, are presented here. Most of these analogs exhibit potent and highly selective binding to sst2 receptors, and all of the analogs are antagonists inhibiting receptor signaling. Based on their consensus 3D structure, the pharmacophore of the sst2-selective antagonist has been defined. The pharmacophore involves the side chains of Cpa2, DTrp/DAph(Cbm)8, and Lys9, with the backbone for most of the sst2-selective antagonists comprised a Type-II' beta-turn. Hence, the sst2-selective antagonist pharmacophore is very similar to the sst2-selective agonist pharmacophore previously described.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18655144      PMCID: PMC2789648          DOI: 10.1002/bip.21060

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  37 in total

1.  Conformational analysis of a potent SSTR3-selective somatostatin analogue by NMR in water solution.

Authors:  Margarida Gairí; Pilar Saiz; Sergio Madurga; Xavier Roig; Judit Erchegyi; Steven C Koerber; Jean Claude Reubi; Jean E Rivier; Ernest Giralt
Journal:  J Pept Sci       Date:  2006-02       Impact factor: 1.905

2.  Efficient analysis of protein 2D NMR spectra using the software package EASY.

Authors:  C Eccles; P Güntert; M Billeter; K Wüthrich
Journal:  J Biomol NMR       Date:  1991-07       Impact factor: 2.835

3.  In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat.

Authors:  Y C Patel; T Wheatley
Journal:  Endocrinology       Date:  1983-01       Impact factor: 4.736

4.  Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Lukas Durrer; Steven C Koerber; Judit Erchegyi; Jean Claude Reubi; Jean E Rivier; Roland Riek
Journal:  J Med Chem       Date:  2005-01-27       Impact factor: 7.446

5.  Torsion angle dynamics for NMR structure calculation with the new program DYANA.

Authors:  P Güntert; C Mumenthaler; K Wüthrich
Journal:  J Mol Biol       Date:  1997-10-17       Impact factor: 5.469

6.  Exploration of the DTrp-NMeLys motif in the search for potent somatostatin antagonists.

Authors:  W G Rajeswaran; William A Murphy; John E Taylor; David H Coy
Journal:  Bioorg Med Chem       Date:  2002-06       Impact factor: 3.641

7.  A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.

Authors:  C Gilon; M Huenges; B Mathä; G Gellerman; V Hornik; M Afargan; O Amitay; O Ziv; E Feller; A Gamliel; D Shohat; M Wanger; O Arad; H Kessler
Journal:  J Med Chem       Date:  1998-03-12       Impact factor: 7.446

8.  Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan.

Authors:  Jean Rivier; Judit Erchegyi; Carl Hoeger; Charleen Miller; William Low; Sandra Wenger; Beatrice Waser; Jean-Claude Schaer; Jean Claude Reubi
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

9.  Novel sst(4)-selective somatostatin (SRIF) agonists. 2. Analogues with beta-methyl-3-(2-naphthyl)alanine substitutions at position 8.

Authors:  Judit Erchegyi; Botond Penke; Lajos Simon; Scott Michaelson; Sandra Wenger; Beatrice Waser; Renzo Cescato; Jean-Claude Schaer; Jean Claude Reubi; Jean Rivier
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

10.  Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.

Authors:  Christy Rani R Grace; Steven C Koerber; Judit Erchegyi; Jean Claude Reubi; Jean Rivier; Roland Riek
Journal:  J Med Chem       Date:  2003-12-18       Impact factor: 7.446

View more
  5 in total

1.  Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.

Authors:  Judit Erchegyi; Renzo Cescato; Christy Rani R Grace; Beatrice Waser; Véronique Piccand; Daniel Hoyer; Roland Riek; Jean E Rivier; Jean Claude Reubi
Journal:  J Med Chem       Date:  2009-05-14       Impact factor: 7.446

2.  Ring size in octreotide amide modulates differently agonist versus antagonist binding affinity and selectivity.

Authors:  Christy Rani R Grace; Judit Erchegyi; Manoj Samant; Renzo Cescato; Veronique Piccand; Roland Riek; Jean Claude Reubi; Jean E Rivier
Journal:  J Med Chem       Date:  2008-04-12       Impact factor: 7.446

Review 3.  Prospective of ⁶⁸Ga-radiopharmaceutical development.

Authors:  Irina Velikyan
Journal:  Theranostics       Date:  2013-12-10       Impact factor: 11.556

Review 4.  The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.

Authors:  Oanh Vu; Brian Joseph Bender; Lisa Pankewitz; Daniel Huster; Annette G Beck-Sickinger; Jens Meiler
Journal:  Molecules       Date:  2021-12-30       Impact factor: 4.411

5.  DOTA-Derivatives of Octreotide Dicarba-Analogs with High Affinity for Somatostatin sst2,5 Receptors.

Authors:  Alessandro Pratesi; Mauro Ginanneschi; Marco Lumini; Anna M Papini; Ettore Novellino; Diego Brancaccio; Alfonso Carotenuto
Journal:  Front Chem       Date:  2017-02-23       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.